Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol PR vs Tapentadol PR + Pregabalin in Severe Chronic Low Back Pain with Neuropathic Component
NCT01352741Phase 4Completed
- Sponsor
- Grünenthal GmbH
- Start
- Mar 2011
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 4 trial of tapentadol in chronic low back pain (CLBP), neuropathic pain, sponsored by Grünenthal GmbH. Started Mar 2011; status: completed.
02
Drugs
tapentadol
03
Conditions
chronic low back pain (CLBP)neuropathic pain
Beyond the preview
Go deeper on NCT01352741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01352741.